|
|
Volumn 8, Issue 3, 2002, Pages 201-213
|
|
Nitric-oxide releasing molecules: A new class of drugs with several major indications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID;
2 FLUORO A METHYL(1,1' BIPHENYL) 4 ACETIC ACID 4 (NITROXY)BUTYL ESTER;
3 [4 (6 METHOXY A METHYL 2 NAPHTHALENEACETYLOXY) 3 METHOXYPHENYL] 2 PROPENOIC ACID 4 (NITROXY)BUTYL ESTER;
4 (NITROXY)BUTANOIC ACID 4 ACETYLAMINOPHENYL ESTER;
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER;
ALIPHATIC COMPOUND;
AROMATIC COMPOUND;
CARBACHOL;
DICLOFENAC DERIVATIVE;
DRUG DERIVATIVE;
FLURBIPROFEN;
FLURBIPROFEN 4 NITROXYBUTYL ESTER;
FORMYLMETHIONYLLEUCYLPHENYLALANINE;
GLUCOCORTICOID;
KETOPROFEN DERIVATIVE;
NCX 1015;
NCX 2216;
NCX 701;
NEW DRUG;
NITRATE;
NITRIC OXIDE;
NITRIC OXIDE DONOR;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PREDNISOLONE;
PREDNISOLONE 21 (4' NITROXYMETHYL) BENZOATE;
PROSTAGLANDIN;
PROSTAGLANDIN INHIBITOR;
PROSTAGLANDIN SYNTHASE;
STEROID;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ACUTE HEART INFARCTION;
AGED;
ALZHEIMER DISEASE;
ANIMAL CELL;
ANIMAL TISSUE;
BLADDER INSTABILITY;
CARDIOVASCULAR DISEASE;
CHEMICAL STRUCTURE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INFLAMMATORY DISEASE;
MOUSE;
NONHUMAN;
OSTEOPOROSIS;
PAIN;
PRIORITY JOURNAL;
RAT;
RESPIRATORY TRACT DISEASE;
REVIEW;
RHEUMATIC DISEASE;
SUBSTITUTION THERAPY;
SUSTAINED DRUG RELEASE;
TREATMENT INDICATION;
URINE INCONTINENCE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
HUMANS;
NITRIC OXIDE;
NITRIC OXIDE DONORS;
STEROIDS;
|
|
EID: 0036235003
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612023396357 Document Type: Review |
|
Times cited : (98)
|
|
References (73)
|
